Format

Send to

Choose Destination
J Cosmet Laser Ther. 2008 Jun;10(2):110-3. doi: 10.1080/14764170802054138.

Eyelash enhancement properties of topical dechloro ethylcloprostenolamide.

Author information

1
Laser and Cosmetics, San Mateo, CA 94401, USA.

Abstract

OBJECTIVE:

To assess subjective reports by users of MD Lash Factor(TM) that it improved the appearance of their eyelashes, especially in length.

METHODS:

A randomized, double-blind, clinical trial was performed on 34 healthy volunteers who were randomly assigned to one of three different treatment groups of varying concentrations of the key ingredient (dechloro ethylcloprostenolamide, a novel synthetic topical prostaglandin analogue) and a placebo group.

RESULTS:

All treatment groups demonstrated a statistically significant increase in eyelash length after 4 weeks of daily use. Group A: 1.69 mm, Group B: 1.94 mm, Group D: 1.44 mm, and Group C (placebo): 0.63 mm. There were no complications. Fifteen patients reported minimal initial transient irritation.

CONCLUSION:

Subjective reports by users of improved appearance in their eyelashes were confirmed. Use of dechloro ethylcloprostenolamide had minimal side effects.

PMID:
18569264
DOI:
10.1080/14764170802054138
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center